ID   CL1-5 Fut8-KD
AC   CVCL_C8P6
SY   CL1-5 FUT8 KD; CL1-5/shFUT8
DR   BTO; BTO:0006506
DR   Wikidata; Q123030934
RX   PubMed=23267084;
RX   PubMed=28678517;
CC   Population: Chinese; Taiwan.
CC   Knockout cell: Method=shRNA knockdown; HGNC; 4019; FUT8.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D521 ! CL1-5
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
RX   PubMed=23267084; DOI=10.1073/pnas.1220425110;
RA   Chen C.-Y., Jan Y.-H., Juan Y.-H., Yang C.-J., Huang M.-S., Yu C.-J.,
RA   Yang P.-C., Hsiao M., Hsu T.-L., Wong C.-H.;
RT   "Fucosyltransferase 8 as a functional regulator of nonsmall cell lung
RT   cancer.";
RL   Proc. Natl. Acad. Sci. U.S.A. 110:630-635(2013).
//
RX   PubMed=28678517; DOI=10.1021/jacs.7b03729;
RA   Tseng T.-H., Lin T.-W., Chen C.-Y., Chen C.-H., Lin J.-L., Hsu T.-L.,
RA   Wong C.-H.;
RT   "Substrate preference and interplay of fucosyltransferase 8 and
RT   N-acetylglucosaminyltransferases.";
RL   J. Am. Chem. Soc. 139:9431-9434(2017).
//